SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of BioMed Realty Trust, Inc. (NYSE: BMR) breached their fiduciary duties in connection with the proposed sale of the Company to Blackstone Real Estate Partners VIII.
BioMed operates as a real estate investment trust (REIT) that focuses on providing real estate to the life science industry in the United States.
On October 8, 2015, BioMed announced it had signed a definitive merger agreement with Blackstone. Under the terms of the agreement, Blackstone will acquire BioMed for $ 23.75 per share in cash.
The investigation concerns whether BioMed’s board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for BioMed’s shares of common stock. Nationally recognized Johnson & Weaver, which focuses its practice on shareholder rights, is investigating whether the proposed deal price represents adequate consideration, especially given that one Wall Street analyst has a $26.00 price target on the stock which is far more than the $23.75 offer price. BioMed stock traded at $25.11 earlier this year.
If you are a shareholder of BioMed and believe the proposed buyout price is too low or you’re interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker (email@example.com) at 619-814-4471. If emailing, please include a phone number where you can be reached.
About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.